Due to an increasing emergence of new and drug-resistant strains of the influenza A virus (IAV), developing novel measures to combat influenza is necessary. We have previously shown that inhibiting Wnt/β-catenin pathway reduces IAV infection. In this study, we aimed to identify antiviral human microRNAs (miRNAs) that target the 
| INTRODUCTION
Influenza A virus (IAV) infection causes annual epidemics and recurring pandemics, leading to substantial morbidity and mortality, as well as significant economic losses. IAV belongs to the family Orthomyxoviridae and has a segmented, negative-sense, and singlestranded RNA genome. Although vaccines remain a major means of prevention, a significant amount of time is required to develop and produce an effective vaccine against a new virus strain (Soema, Kompier, Amorij, & Kersten, 2015) . Furthermore, vaccines need to be reformulated annually due to the frequent emergence of new viruses (Houser & Subbarao, 2015) . Antiviral drugs, on the other hand, are essential for treatment and prophylaxis. However, the error-prone nature of the influenza RNA polymerase, due to its lack of proofreading-repair activity, makes the virus highly susceptible to mutation, resulting in its resistance to antivirals (Watanabe et al., 2014) . For example, there has been rapid emergence of IAV strains that are resistant to amantadine and rimantadine, and these antivirals are thus no longer recommended for anti-influenza treatment (Barr et al., 2007; Bright et al., 2005) . Resistance against neuraminidase inhibitors, such as oseltamivir and zanamivir as well as newly developed peramivir and laninamivir, has also been reported (Barrett & McKimm-Breschkin, 2014; Hurt et al., 2009; Kamali & Holodniy, 2013; Orozovic, Orozovic, Jarhult, & Olsen, 2014) . Therefore, it is increasingly urgent to develop drugs that target host factors rather than viral proteins, which is less likely to cause drug resistance.
The small coding capacity of IAV requires it to utilise the host cell machinery for its life cycle (Watanabe, Watanabe, & Kawaoka, 2010; York, Hutchinson, & Fodor, 2014) . Many host proteins and signalling pathways regulate IAV infection at different stages. Early in 2003, Wurzer et al. (2003) discovered that efficient IAV propagation depends on the activation of host caspase-3, a central player in apoptosis, as the presence of a caspase-3 inhibitor in cells strongly impairs viral replication. Several studies have shown that IAV stabilises the p53 protein, activates p53 signalling and consequently induces apoptosis in host cells (Nailwal, Sharma, Mayank, & Lal, 2015; Turpin et al., 2005; Zhirnov & Klenk, 2007) . Recently, cyclophilin A was found to interact with the IAV M1 protein and thus to impair early viral replication (X. Liu et al., 2012) . IAV also interacts with many other cellular pathways, including the NF-κB, PI3K/Akt, MAPK, PKC/PKR, and TLR/RIG-I signalling cascades, to overcome host defences against the virus (Gaur, Munjhal, & Lal, 2011; Ludwig & Planz, 2008; .
MicroRNAs (miRNAs) are~22-nt small noncoding RNAs that posttranscriptionally regulate gene expression by binding the 3′-untranslated region (3′-UTR) of a target mRNA to inhibit protein translation or degrade mRNA (Y. Wang, Stricker, Gou, & Liu, 2007) .
Several thousand miRNAs have been identified in plants, animals, and viral genomes (Akhtar, Micolucci, Islam, Olivieri, & Procopio, 2016) . miRNAs are key modulators in diverse signalling pathways (Zamore & Haley, 2005) . Increasing evidence indicates that miRNAs also participate in host-virus interactions and play a pivotal role in the regulation of viral replication. For example, miR-122, a liverspecific miRNA, facilitates viral replication by targeting the 5′-UTR of hepatitis C virus RNA (Thibault et al., 2015) . Cellular miR-24 and miR-93 target the viral large protein (L protein) and phosphoprotein (P protein) genes of vesicular stomatitis virus (Otsuka et al., 2007) . In addition, miR-323, miR-491, and miR-654 inhibit replication of H1N1 IAV by binding the PB1 gene (Song, Liu, Gao, Jiang, & Huang, 2010) . miRNA can also modulate the type I interferon (IFN) system to combat viral infection. Wang et al. has demonstrated that IFNinduced miR-155 positively regulates the host antiviral innate immune response via type I IFN signalling by targeting suppressor of cytokine signalling 1 (SOCS1; P. Wang et al., 2010) .
We have recently demonstrated a beneficial role of Wnt/β-catenin signalling in IAV infection. The activation of Wnt/β-catenin with Wnt3a enhances influenza virus replication, whereas the inhibition of the pathway with iCRT14 decreases influenza infection (More et al., 2018) . In the present study, we sought to identify miRNAs that regulate IAV replication by modulating the Wnt/β-catenin pathway.
Here, we report the systematic screening of a miRNA expression library and identification of 20 miRNAs that modulate the activity of the Wnt/β-catenin pathway. Four selected miRNAs that inhibit the pathway, miR-193b, miR-548f-1, miR-1-1, and miR-509-1, were found to have anti-IAV activities. miR-193b suppressed IAV replication by targeting β-catenin.
| RESULTS

| Screening of miRNAs that alter Wnt/β-catenin signalling activity
The Wnt/β-catenin signalling pathway plays an important role in various biological processes. Several studies have shown that a number of miRNAs modulate the activity of Wnt/β-catenin signalling by regulating the expression of the pathway-related components (Anton, Chatterjee, Simundza, Cowin, & Dasgupta, 2011; T. Hu et al., 2016; K. Huang et al., 2010) . To systematically identify miRNAs that regulate Wnt/β-catenin signalling, we constructed a miRNA expression library composed of 738 human miRNA precursor expression vectors and performed screening using a TOPflash reporter luciferase assay as a readout for Wnt/β-catenin signalling activity ( Figure 1a ).
The TOPflash reporter vector contains three copies of T-cell factor (TCF)/lymphoid enhancer-binding factor (LEF) binding sites upstream of the luciferase reporter gene. The initial screening was performed in 96-well plates with three replicates. Human HEK293T cells were transfected with a TOPflash luciferase reporter plasmid, miRNA expression plasmid, and the normalisation vector, pRL-TK vector, for 24 hr and were then stimulated with Wnt3a for 24 hr, followed by the dual luciferase assay. Among 738 miRNAs, 85 miRNAs were found to up-regulate and 20 to down-regulate luciferase activity with a fold change ≥2, resulting in a hit rate of 14.2% ( Figure 1a and Table S1 ).
To further validate the primary screen data, we repeated the reporter assay with a FOPflash vector containing mutated TCF binding sites as a negative control for TOPflash activity. If a miRNA changed the FOPflash activity similar to the TOPflash activity, the miRNA was considered to be a false positive. We selected approximately equal numbers of up-and down-regulating miRNAs (up, 24 miRNAs with a greater than or equal to threefold change, and down, 20 miRNAs with a ≥2-fold change, Figure 1b) . Among the 20 down-regulating miRNAs, miR-548f-1, 548f-2, and 548f-4 have an identical mature miRNA, and thus, miR-548f-2 and 548f-4 were excluded. TOPFlash and FOPlash firefly luciferase activities, normalised to pRL-TK Renilla luciferase activity, are shown in Figure 1c for the up-regulating miRNAs and Figure 1d for down-regulating miRNAs. A ratio of normalised TOPflash/normalised FOPflash are presented in Figure 1e ,f. Using a TOPflash/FOPflash ratio of 1.5 as a cut-off value, we identified 15 and five miRNAs that up-and down-regulated the Wnt/β-catenin signalling pathway, respectively.
| Identification of miRNAs with anti-IAV activities
We then tested whether the above-identified miRNAs that downregulated the Wnt/β-catenin pathway could inhibit IAV infection.
Among the five miRNAs (miR-193a, miR-193b, miR-548f-1, miR-1-1, and miR-509-1) that down-regulated Wnt/β-catenin signalling, miR-193a and miR-193b Figure 2b ). Western blot analysis showed that overexpression of miR-193b, miR-548f-1, miR-1-1, and miR-509-1 in HEK293 cells reduced viral NP protein expression by 73 ± 14%, 42 ± 9%, 61 ± 25%, and 35 ± 19%, respectively, and NS1 protein expression by 98 ± 1%, 61 ± 21, 63 ± 18, and 30 ± 15%, respectively (Figure 2c,d ). These miRNAs also reduced the mRNA levels of NP, NS1, and PB1 in cells by 30-60% (Figure 2e ). Furthermore, progeny virus production in the culture media was suppressed by all of the miRNAs (Figure 2f ). Immunostaining of NP revealed that these miRNAs also led to a decrease in IAV-infected cells (Figure 2g ). It is noteworthy that miR-509-1 inhibited the Wnt/β-catenin signalling, the second most but merely showed moderate suppression of the IAV infection, suggesting a possible offtarget effect of the miRNA. Taken together, the data showed that the miRNAs that down-regulated the Wnt/β-catenin signalling pathway reduced IAV infection.
| Further characterisation of the anti-IAV activities of miR-193b
Given that miR-193b suppressed Wnt/β-catenin signalling and the viral mRNA and protein levels more than other miRNAs, we selected miR-193b for further investigation. First, we determined whether the effects of miR-193b on IAV infection were cell type dependent. The lung is the primary site of IAV infection, and thus, we chose human lung epithelial A549 cells for this purpose. Due to the low transfection efficiency of plasmid into A549 cells, we used a lentivirus to overexpress miR-193b. Lentivirus infection efficiencies under our conditions were nearly 100% as revealed by EGFP images (Figure 3a 2 Effects of miRNAs that up-regulate Wnt/β-catenin signalling on IAV infection. (a,b) HEK293 cells were transfected with a pENTRmiRNA or its control vector (miR-Con) for 72 hr. The transfection efficiency was monitored by the GFP signal and the cells were counterstained with Hoechst 33342 (blue). miRNA expression was determined by real-time PCR, normalised to β-actin, and expressed as a ratio to miR-Con. (c-f) HEK293 cells were transfected with pENTR-miRNA or miR-con for 24 hr, followed by infection with A/PR/8/34 at an MOI of 0.01 for 48 hr. NP and NS1 protein levels were determined by western blotting, densitometrically quantified and normalised to β-actin. NP, NS1, and PB1 mRNA expression was determined by real-time PCR and normalised to β-actin. Virus yields in the medium were titrated by the TCID 50 assay. (g) HEK293 cells were transfected with a pENTR-miRNA or miR-con vector for 24 hr, followed by infection with PR8 IAV at an MOI of 0.5 for 16 hr. Immunofluorescent staining was performed to detect viral NP (red). GFP images show cells overexpressing the miRNAs. The cells were counterstained with Hoechst 33342 (blue). Data are expressed as the mean ± SE of three independent experiments. *P < 0.05 versus miR-Con, **P < 0.01 versus miR-Con, ***P < 0.001 versus miR-Con, and ****P < 0.0001 versus miR-Con (b and f: one-way ANOVA, Bonferroni's multiple comparisons test; d and e: two-way ANOVA, Bonferroni's multiple comparisons test) H1N1 virus, and H3N2 is a virus strain that causes seasonal flu annually and endemic outbreaks. To obtain a proper readout of the luciferase activities, we first optimised the dose of the viruses with MOIs of 0.001, 0.005, 0.01, 0.05, and 0.1. The dose that resulted in a ratio (firefly/renilla) between 10 and 100 was selected (data not shown). The results showed that overexpression of miR-193b inhibited IAV infection of all tested strains by 45-73% in HEK293 cells and by 25-76% in A549 cells (Figure 4a, b) , indicating that the antiviral effect of miR-193b was not strain dependent.
| Knockout of miR-193b with CRISPR/Cas9 enhances IAV infection
To determine the effects of endogenous miR-193b on IAV infection, we knocked out miR-193b with CRISPR/Cas9 and determined their effects on IAV infection. Two single guide RNAs (sgRNAs) were designed to target two regions of pre-miR-193b (Figure 5a ). A549 cells were infected with a sgRNA-lentiCRISPR virus or a control virus, and one clone was chosen from each sgRNA after puromycin selection. The surveyor mutation assay showed that the mutations were generated in both miR-193b knocked-out clones (Figure 5b ). DNA sequencing revealed that one base was inserted in the sgRNA1 clone, and two bases were deleted in the sgRNA2 clone (Figure 5c ). infection. A549 cells were infected with miR-193b or miR-Con lentivirus (MOI 100) for 48 hr, followed by infection with A/PR/8/34 (MOI 0.01) for 48 hr. NP and NS1 protein expression was detected by western blotting, densitometrically quantified, and normalised to β-actin. Viral NP, NS1, and PB1 mRNA expression was determined by real-time PCR and normalised to β-actin. The virus yield in the medium was titrated by the TCID 50 assay. (h,i) miR-193b or miR-Con lentivirus-infected A549 cells were infected with IAV at MOI 0.5 for 8 hr. NP and NS1 protein levels in the infected cells were detected by western blotting and quantified. Data are expressed as the mean ± SE of three independent experiments. *P < 0.05 versus miR-Con and **P < 0.01 versus miR-Con (b and g: Student's t-test; c: one-way ANOVA, Bonferroni's multiple comparisons test; e, f, and i: two-way ANOVA, Bonferroni's multiple comparisons test) 
| miR-193b suppresses cyclin D1 and induces G0/G1 arrest
As a downstream target of Wnt/β-catenin signalling, cyclin D1 plays an important role in the G1-S transition of the cell cycle. Therefore, we further determined whether miR-193b reduced cyclin D1 expression. To test whether miR-193b was able to affect the cell cycle progression, miR-193b-infected A549 cells were synchronised by cultivation in serum-free medium for 48 hr and then allowed to re-enter the cell cycle by culturing them in medium containing 10% FBS for 18 and 30 hr. The cells were stained with propidium iodide and analysed by (e-g) sgRNA1, sgRNA2, or control vector (Con)-treated A549 cells were infected with A/PR/8/34 at MOI 0.01 for 48 hr. Viral NP levels were determined with western blotting (e), and densitometrically quantified and normalised to β-actin (f). The progeny virus was determined by TCID 50 assay (g). *P < 0.05 versus Con, **P < 0.01 versus Con, and ***P < 0.001 versus Con (one-way ANOVA, Bonferroni's multiple comparisons test) flow cytometry. Approximately 72% of miR-193b-infected cells were in the G0/G1 phase compared with 60-62% of miR-Con-treated cells (Figure 8g ) at both time points. On the contrary, miR-193b overexpression decreased the progression of A549 cells to S phase. These data indicated that miR-193b suppressed cyclin D1 expression and inhibited the cell cycle transition from G0/G1 to S.
| miR-193b hinders the nuclear entry of vRNP
IAV infection involves a complex series of nuclear import and export events. Thus, we examined whether miR-193b was able to inhibit vRNP entry into the nucleus. We infected miR-193b-overexpressing The 3′-UTR reporter assay. HEK293T cells were transfected with a miR-193b expression vector and a 3′-UTR luciferase reporter plasmid for 48 hr. Firefly luciferase activity was normalised to pRL-TK Renilla luciferase activity and then expressed as a ratio to the vector control (miR-Con). (c,d) Effect of miR-193b on endogenous target proteins in HEK293 cells. HEK293 cells were transfected with a miR-193b overexpression plasmid for 48 hr. LEF1, β-catenin, and FZD4 protein expression was detected by western blotting, densitometrically quantified, and normalised to β-actin. (e,f) Effect of miR-193b on endogenous β-catenin in A549 cells. A549 cells were infected with a miR-193b lentivirus for 48 hr. β-catenin protein expression was detected by western blotting, densitometrically quantified, and normalised to β-actin. (g,h) Endogenous β-catenin in miR-193b-knockout A549 cells. β-Catenin protein expression in sgRNA1, sgRNA2, or control vector-treated A549 cells was determined by western blotting and quantified by normalisation to β-actin. Data are expressed as the mean ± SE of three independent experiments. *P < 0.05 versus miR-Con, **P < 0.01 versus miR-Con, ***P < 0.001, and ****P < 0.0001 versus miR-Con (b and d: two-way ANOVA, Bonferroni's multiple comparisons test; f: Student's t-test; h: one-way ANOVA, Bonferroni's multiple comparisons test)
shown in Figure 10a ,b, the fluorescence signal of Ki-67, a marker for cell proliferation, was significantly reduced in serum-starved cells compared with the control. By contrast, NP nuclear translocation was 2.3-fold higher in control cells than in the cells that were in G0/G1 cell cycle arrest. These data indicated that G0/G1 cell cycle arrest indeed suppressed vRNP entry into the nucleus. The cells were then infected with A/PR/8/34 (MOI 0.01) for 48 hr. NP protein expression was detected by western blotting (a,d), quantified and normalised to β-actin (b,e). Progeny virus was determined by TCID 50 assay (c,f). Data are expressed as the mean ± SE of three independent experiments. *P < 0.05 and **P < 0.01 (one-way ANOVA, Tukey's multiple comparison test). NS: not significant FIGURE 8 miR-193b suppresses cyclin D1 and induces G0/G1 cell cycle arrest. (a-c) HEK293 cells were transfected with a miR-193b expression plasmid for 48 hr, or A549 cells were infected with a miR-193b lentivirus (MOI 100) for 48 hr. The mRNA (a) and protein (b) levels of cyclin D1 were detected by real-time PCR and western blotting, respectively. Protein expression was densitometrically quantified and normalised to β-actin (c). (d-f) HEK293 cells were seeded in 12-well plates and transfected with a miR-193b plasmid (0.5 μg) alone or along together with p-CMV-CCND1 (0.5 μg, Addgene #19927) expression plasmid. The cells were then infected with A/PR/8/34 (MOI 0.01) for 48 hr. NP protein expression was detected by western blotting, quantified, and normalised to β-actin. Progeny virus was determined by TCID 50 assay. (g) miR-193b lentivirus-infected A549 cells were serum-starved for 24 hr and then cultured in medium containing 10% fetal bovine serum for 18 and 30 hr. The cells were stained with propidium iodide. The DNA content was measured by flow cytometry. The cell cycle phase distribution was examined. Data are expressed as the mean ± SE of three independent experiments. (a,c, and g) *P < 0.05 versus miR-Con, **P < 0.01 versus miRCon (two-way ANOVA, Bonferroni's multiple comparisons test). (e and f) *P < 0.05 and **P < 0.01 (one-way ANOVA, Tukey's multiple comparison test)
| IAV infection causes down-regulation of miR-193b in vitro
To assess the effect of IAV infection on miR-193b expression, A549 or Progeny virus production in the lungs was also decreased at 7 dpi although it did not reach a significant level (Figure 12e ). Taken together, these results confirm the antiflu activities of miR-193b in vivo.
FIGURE 9 miR-193b suppresses IAV vRNP nuclear import. (a) miR-193b or miR-Con lentivirus-infected A549 cells were infected with A/PR/8/ 34 at an MOI of 10 for 2, 3, 5, and 8 hr. Viral NP (red) was immunostained, and the nuclei (blue) were counterstained. (b) Cells with intense NP signal localised (centred) in the nucleus were considered to exhibit nuclear localisation and counted. The percent of cells with NP nuclear localisation at different times was quantified. Data are expressed as the mean ± SE of three independent experiments. ***P < 0.001 versus miRCon (two-way ANOVA, Bonferroni's multiple comparisons test)
| DISCUSSIONS
As influenza pathogenesis is determined in part by the host response, understanding the key host modulators of viral infection and virus-induced disease is a promising approach to host-oriented drug development for preventing the disease. The Wnt/β-catenin signalling pathway has been shown to play an important role in virus replication (More et al., 2018; Shapira et al., 2009 ) and virus-induced immune responses (Hillesheim, Nordhoff, Boergeling, Ludwig, & Wixler, 2014) . Identification of miRNAs that interfere with IAV replication by modulating Wnt/β-catenin will provide new insights into the miRNA-Wnt/β-catenin signalling-IAV interaction network. In the present study, using miRNA library screening, we identified 15 and five miRNAs that up-and down-regulated Wnt/β-catenin signalling, FIGURE 10 Effect of G0/G1 cell cycle arrest on IAV NP nuclear import. G0/G1-arrested A549 cells were achieved by culturing the cells in medium containing 0.2% of fetal bovine serum for 72 hr. Control cells were first serum-starved in medium containing 0.2% fetal bovine serum for 48 hr and then cultured in complete medium (containing 10% fetal bovine serum) for 24 hr to allow them to enter the normal cell cycle. (a) Ki-67 was immunostained (green), and cell nuclei were counterstained (blue). All of the four miRNAs that inhibit Wnt/β-catenin signalling reduced viral protein levels. It is noted that to the extent that a miRNA inhibits Wnt/β-catenin signalling does not exactly correlate with its anti-influenza virus activities (Figures 1f and 2d) . It is likely that, in addition to Wnt/β-catenin signalling, these miRNAs also target other pathways. Among the down-regulating miRNAs, miR-193b was the most effective suppressor of the Wnt/β-catenin signalling pathway. miR-193b is considered to be a biomarker of various cancers because it is down-regulated in lung cancer (H. Hu, Li, Liu, & Ni, 2012) , hepatocellular carcinoma , prostate cancer (Rauhala et al., 2010) , and melanoma (Chen et al., 2010) . By contrast, miR-193b has been demonstrated to suppress carcinoma cell proliferation, migration, invasion, and metastasis (Leivonen et al., 2009; Wu, Lin, Zhuang, & Liang, 2009) , suggesting that miR-193b may function as a tumour suppressor. Excluding hepatitis B virus-associated hepatocellular carcinoma (Mao et al., 2014) , the role of miR-193b in modulating viral infection has rarely been studied to date. In this study, we found that miR-193b strongly suppressed IAV infection. We further Figures 6 and 7) . To the best of our knowledge, (Harmon et al., 2016; Smith, Jeng, McWeeney, & Hirsch, 2017) . Previous studies have also shown that the deletion of Wnt pathway components significantly impacts IAV replication and interferon production (Shapira et al., 2009; Watanabe et al., 2014) . β-Catenin is a part of adherens junctions at the cell membrane and acts as a transcription factor that interacts with LEF/TCF to regulate the Wnt/β-catenin pathway.
Increasing evidence has suggested the importance of β-catenin in viral replication, but some discrepancies exist. Hillesheim et al. (2014) showed that β-catenin accumulates in the nucleus after IAV infection and that β-catenin supports IRF3-dependent transcription of genes responsible for the cellular innate immune response, such as IFN-β and ISGs. By contrast, Baril et al. (2013) (Ahrens, Romereim, & Dudley, 2011; Ishitani, Matsumoto, Chitnis, & Itoh, 2005) . It has also been reported that Drosophila TCF activates gene transcription in the presence of Armadillo, the Drosophila homologue of β-catenin. However, Drosophila TCF actually functions as a repressor in the absence of Armadillo (Cavallo et al., 1998; de Lau & Clevers, 2001 ). This may explain why LEF1 overexpression alone even resulted in a decrease of IAV NP protein expression and virus production (Figure 7d-f) . Furthermore, β-catenin has a transactivation domain but not LEF-1 (Vleminckx, Kemler, & Hecht, 1999) . These studies suggest that LEF1 requires β-catenin for its transcription activation activity. Because miR-193b
reduces the protein levels of both β-catenin and LEF1, overexpression of LEF1 alone cannot rescue the miR-193b effects on IAV infection. and ERK pathways were modulated (Jin et al., 2015) .
A good number of studies suggest that crosstalk occurs between the cell cycle and Wnt signalling. It has been well demonstrated that Wnt/β-catenin signalling stimulates the G1/S transition and promotes cell cycle progression and therefore proliferation through transcriptional up-regulation of target genes that encode, for example, c-Myc and cyclin D (Niehrs & Acebron, 2012) . By contrast, the β-catenin levels increase during the G1/S transition and peak during G2/M in normal and transformed epithelial cells (Olmeda, Castel, Vilaro, & Cano, 2003) . It was recently found that the mitotic CDK14/cyclin Y complex promotes Wnt/β-catenin signalling through phosphorylation of the LRP6 coreceptor (Davidson & Niehrs, 2010) . Cyclin D1 is a major regulator of the progression of cells into the proliferative stage of the cell cycle and is necessary for cells to enter S phase (Baldin, Lukas, Marcote, Pagano, & Draetta, 1993) . Down-regulation of cyclin D1 induces G0/G1 arrest (Masamha & Benbrook, 2009; Radu, Neubauer, Akagi, Hanafusa, & Georgescu, 2003) . We observed that cyclin D1 is markedly down-regulated in miR-193b-overexpressing cells. This is likely due to the combined effect of a reduced Wnt/β-catenin signalling activity and a direct repression by miR-193b because cyclin D1 is a well-known down-stream target of Wnt/β-catenin signalling (Shtutman et al., 1999) , and cyclin D1 has been previously shown to be a direct target of miR-193 in cancer cells (Chen et al., 2010) .
Based on the observations that miR-193b reduced cyclin D1
protein levels and induced cell cycle G0/G1 arrest, and that miR-193b and cell cycle G0/G1 arrest suppressed viral vRNP nuclear import, we speculate that miR-193b may inhibit vRNP nuclear import 
| Cell viability assay
Cell viability was determined by using a CellTiter Blue Cell Viability assay kit (Promega, Madison, WI, USA) according to the manufacturer's instructions. Cells were cultured in 96-well plates and were incubated with the CellTiter Blue Reagent at 37°C for 2 hr. Fluorescence was measured using an excitation at 560 nm and an emission at 590 nm on a plate reader.
| miRNA expression library construction
The miRNA overexpression vectors contained the CMV promoter, followed by an EGFP tag, a mature miRNA with flanking sequences (~200 bp at each end), and the SV40 poly(A) terminal sequence. 
| MiRNA target prediction
The bioinformatics prediction tools PicTar (http://pictar.mdc-berlin.
de/), Target Scan (version 5.2; http://www.targetscan.org/), and DIANA-microT-4.0 (http://diana.imis.athena-innovation.gr/) were used to identify potential targets of miR-193b.
| Construction of 3′-UTR luciferase reporter vectors and the IAV reporter vector
The 3′-UTRs of predicted target genes of the miRNAs were PCRamplified and inserted into the pmirGLO dual-luciferase miRNA target expression vector (Promega, Madison, WI) at the NheI and SalI sites.
To detect IAV infection with a luciferase reporter assay, we constructed an IAV reporter vector encoding firefly luciferase under control of the 3′-UTRs of the influenza A/WSN/33 NP segment as previously described (Lutz, Dyall, Olivo, & Pekosz, 2005) . Briefly, the 3′-and 5′-UTRs of the influenza A/WSN/33 NPs were amplified by PCR and inserted into the RNA polymerase I promoter/terminator cassette of the pHH21 vector (a kind gift from Dr. Yoshi Kawaoka, U. Wisconsin) at BsmB I sites (pHH21-NP-3′-UTR-LUC-NP-5′-UTR).
All inserts were confirmed by DNA sequencing.
| Production of miRNA lentivirus or adenovirus
A lentiviral vector was cotransfected with psPAX2 and pMD2G
(Cellecta, Mountain View, CA, USA) into HEK293T cells using polyethylenimine (PEI, Sigma, St. Louis, MO, USA; 6 μg PEI/μg plasmid) to generate lentivirus expressing miR-193b or the control.
The pENTR-miRNA vector or miR-con was switched into an adenovirus vector using the Gateway technique pAd/CMV/V5-DEST™ (Invitrogen, Carlsbad, CA, USA) as described by the manufacturer. 
| Median tissue culture infective dose (TCID 50 ) assay
Virus titrations were performed according to a protocol adapted from De Vleeschauwer, Van Poucke, Karasin, Olsen, and Van Reeth (2011) .
Briefly, MDCK cells were seeded in a 96-well cell culture plate at a density of 20,000 cells per well. One day after seeding, the cells were inoculated with 50 μl of 10-fold serially diluted samples. After 1 hr, the inoculum was removed, followed by the addition of serum-free DMEM containing 1-μg/ml TPCK-trypsin. The cells were observed daily for 5 days for the appearance of cytopathic effects. Virus titres were calculated according to the method of Reed and Muench (Reed & Hugo, 1938) .
| Reverse transcription and real-time PCR
To measure mRNA expression levels, total RNA was extracted using TRI Reagent® (Molecular Research Center, Cincinnati, OH, USA). 
| Real-time PCR for miRNA expression
Total RNA was extracted using TRI Reagent® and then polyadenylated using the Poly(A) Polymerase Tailing Kit (NEB, MA, USA). Briefly, a 10-μl reaction containing 1 μg total RNA, 1 μl of 10 × reaction buffer, 1 μl of 10 mM ATP and 5 units of Escherichia coli Poly(A) Polymerase was incubated at 37°C for 20 min, followed by enzyme inactivation at 65°C for 20 min. After polyadenylation, reverse transcription was performed using 10 μl of the polyadenylated reaction product, 1 μl of 0.5 μM Poly(T) adapter, 1 μl of 10 mM dNTP, and 1 μl of M-MLV Reverse Transcriptase. The reaction was incubated at 37°C for 50 min and then terminated by heating at 70°C for 15 min.
Real-time PCR were performed using SYBR green PCR master mix with the above-described conditions. The expression of a miRNA was analysed according to the comparative Ct method by normalisation to U48 or U6 small nuclear RNA using the 2 −ΔCt method.
| Luciferase reporter assay
For the 3′-UTR reporter assay, HEK293T cells were transfected with 5 ng of 3′-UTR reporter vector, 100 ng of miRNA or miR-con vector using Lipofectamine 2000. Two days after transfection, the cells were harvested for the dual luciferase activity assay.
To Protein bands were visualised using the enhanced chemiluminescence kit (Thermo Fisher Scientific, Rockford, IL, USA). 
| IF staining
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